Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto Oncoclinicas is the research, education, and social responsibility arm of Grupo Oncoclinicas, the largest oncology group in Latin America. Based in Brazil, the institute focuses on advancing cancer treatment through clinical trials, genomic research, and specialized medical education for healthcare professionals. It maintains a prestigious strategic partnership with the Dana-Farber Cancer Institute to facilitate knowledge exchange and implement international standards of oncology care. The institute plays a vital role in the group's ecosystem by integrating scientific innovation with clinical practice, supporting the development of personalized medicine and new therapeutic protocols. Through its extensive network of clinical sites, it provides patients with access to cutting-edge therapies and contributes significantly to the global oncology research community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto Oncoclinicas.